Question: What special consideration are their for surgical care settings in regard to aoresols during the pandemic?

Answer passage (source: CDC):
page_title: Healthcare Infection Prevention and Control FAQs for COVID-19
section_headers: During the COVID-19 pandemic, are there special considerations for surgical and other procedural care settings, including performance of aerosol-generating procedures (AGPs)?
section_content: As part of routine practices, healthcare personnel (HCP) should be applying
Standard Precautions. HCP
should always deliberately assess potential risks of exposure to infectious
material before engaging in activities and procedures in healthcare delivery.
Based on their risk assessment, safe work practices, including engineering
controls that reduce the release of infectious material, administrative
controls, and use of personal protective equipment (PPE) should be implemented
at the point of care according to CDC guidelines and standards of practice for
the activity performed.
To reduce SARS-CoV-2 exposure during the COVID-19 pandemic, CDC recommends
that facilities:

consider nonoperative approaches when feasible;
minimize the use of procedures or techniques that might produce infectious aerosols when feasible;
minimize the number of people in the operating or procedure room to reduce exposures;
use the extent of community transmission and an assessment of the likelihood for patient harm if care is delayed to make decisions about cancelling or postponing elective surgeries and procedures; and
implement universal source control measures, which includes having patients wear a cloth face covering (as tolerated) and having HCP wear a facemask at all times while they are in the healthcare facility.

If surgery or procedures cannot be postponed, HCP caring for patients with
suspected or confirmed COVID-19 should adhere to all recommended infection
prevention and control practices for
COVID-19.
This includes:

Using all recommended PPE: an N95 or higher-level respirator (or facemask if respirators are not available), eye protection, gloves, and a gown. 
Respirators with exhalation valves should not be used during surgical procedures as unfiltered exhaled breath would compromise the sterile field.
If shortages exist, N95 or higher-level respirators should be prioritized for procedures involving higher risk techniques (e.g., that generate potentially infectious aerosols) or that involve anatomic regions where viral loads might be higher (e.g., nose and throat, oropharynx, respiratory tract).


As part of routine practice, HCP should also be using additional engineering controls for source control, when applicable (e.g., smoke evacuation devices).

Because COVID-19 can be transmitted asymptomatically, some infected
individuals will not be identified based on clinical signs and symptoms. HCP
providing surgical or procedural care to patients not suspected of having
COVID-19 should use a tiered approach based on the level of community
transmission to inform the need for universal eye protection and respirator
use (see FAQ addressing recommended PPE when caring for asymptomatic patients
who are not suspected to have COVID-19). HCP should continue to use eye
protection or an N95 or higher-level respirator whenever recommended for
patient care as a part of Standard or Transmission-Based Precautions.

Reviewer feedback on this answer:
Starting with second paragraph there are instructions given on how to deal with COVID-19 patients in a surgical setting especially as regards respirators and PPE. However, it does not answer what to do about aerosols in general except for engineering controls which is a vague statement.
The answer provides detailed and relevant information.

Reviewer ratings:
Acceptable
Excellent

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Obstetrical Care
How should the use of N95 respirators be prioritized within obstetric healthcare settings during shortages?
section_content: During respirator shortages, care should be taken to ensure that N95
respirators are reserved for situations where respiratory protection is most
important, such as performance of aerosol-generating procedures on patients
with suspected or confirmed COVID-19 infection. In such shortage situations,
facemasks might be used for other types of patient care.
Alternatives to N95 respirators might be considered where feasible. These
include other classes of NIOSH-approved filtering facepiece respirators, half
facepiece or full facepiece elastomeric respirators, and powered air-purifying
respirators (PAPRs) where feasible. All of these alternatives will provide
equivalent or higher protection than N95 respirators when properly worn.
However, PAPRs and elastomeric respirators should not be used in surgical
settings due to concerns that exhaled air may contaminate the sterile field.
For more information please see: Strategies for Optimizing the Supply of N95
Respirators: Conventional Capacity
Strategies.
When respirator supplies are restored, the facility can switch back to use of
N95 respirators for all care of patients with known or suspected COVID-19
infection. For more information, please see Interim Infection Prevention and
Control Recommendations for Patients with Suspected or Confirmed Coronavirus
Disease 2019 (COVID-19) in Healthcare
Settings.

Reviewer feedback on this answer:
Surgical settings are barely addressed in second paragraph near the end. Perhaps the link provided for the N95 respirator will have more information but it does not specifically address the question in the manner it was intended.
The question is in regards to surgical units but the answer is about respirators and is unrelated.

Reviewer ratings:
Could be Improved
Bad

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Treatment and Management
How are COVID-19 patients treated?
section_content: Not all patients with COVID-19 will require medical supportive care. Clinical
management for hospitalized patients with COVID-19 is focused on supportive
care for complications, including supplemental oxygen and advanced organ
support for respiratory failure, septic shock, and multi-organ failure.
Empiric testing and treatment for other viral or bacterial etiologies may be
warranted.
Corticosteroids are not routinely recommended for treatment of viral
pneumonia or ARDS, due to the potential for prolonging viral replication, as
has been observed with MERS coronavirus and influenza. Corticosteroids should
be avoided unless they are indicated for another reason (e.g., COPD
exacerbation or refractory septic shock following the Surviving Sepsis
Campaign Guidelinesexternal iconexternal
icon).
For information on investigational therapies, see Therapeutic Options for
Patients with COVID-19.

Reviewer feedback on this answer:
Answer does not relate to what to do during surgical setting but rather for what to do with COVID-19 patients in general, specifically when it comes to "supportive care".
The question is asking specifically about preparations surgical areas should take but the answer is about general hospitalizations.

Reviewer ratings:
Bad
Bad